APA (7th ed.) Citation

Wilson, A., Jansen, L. E., Rose, R. V., Gregor, J. C., Ponich, T., Chande, N., . . . Kim, R. B. (2018). HLA‐DQA1‐HLA‐DRB1 polymorphism is a major predictor of azathioprine‐induced pancreatitis in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics, 47(5), 615-620. https://doi.org/10.1111/apt.14483

Chicago Style (17th ed.) Citation

Wilson, A., et al. "HLA‐DQA1‐HLA‐DRB1 Polymorphism Is a Major Predictor of Azathioprine‐induced Pancreatitis in Patients with Inflammatory Bowel Disease." Alimentary Pharmacology & Therapeutics 47, no. 5 (2018): 615-620. https://doi.org/10.1111/apt.14483.

MLA (9th ed.) Citation

Wilson, A., et al. "HLA‐DQA1‐HLA‐DRB1 Polymorphism Is a Major Predictor of Azathioprine‐induced Pancreatitis in Patients with Inflammatory Bowel Disease." Alimentary Pharmacology & Therapeutics, vol. 47, no. 5, 2018, pp. 615-620, https://doi.org/10.1111/apt.14483.